share_log

微芯生物(688321.SH):已有抗猴痘相关研发项目的储备

Shenzhen Chipscreen Biosciences (688321.SH): Has reserves of research and development projects related to monkeypox.

Gelonghui Finance ·  Aug 16 03:54

Shenzhen Chipscreen Biosciences, listed on the Shanghai Stock Exchange, stated on the investor interaction platform on August 16th that the company has reserved research and development projects related to monkeypox, and the CDCS23 project has completed some preclinical work and has excellent antiviral activity.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment